Business
Press Release Jun 16 2021
Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated Jun 16, 2021, titled "Alembic Pharmaceuticals announces its joint venture, Aleor Dermaceuticals Limited receives USFDA Final Approval for Testosterone Topical Solution USP, 30 mg per pump actuation".
About this update from Alembic Pharmaceuticals Limited
[{"type":"text","content":" Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated Jun 16, 2021, titled \"Alembic Pharmaceuticals announces its joint venture, Aleor Dermaceuticals Limited receives USFDA Final Approval for Testosterone Topical Solution USP, 30 mg per pump actuation\". View Attachment","length":491,"tagName":"div"}]